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 ABSTRACT
Background: Tubulointerstitial nephritis (TIN) is a common cause of kidney injury typically seen in 
association with drug exposure, infection or autoimmune diseases. However, TIN with interstitial immune 
complex deposition, without glomerular injury, is rarely observed. Case: We report a case of a 64-year-
old Indian woman admitted for dialysis-requiring renal failure, without involvement of other organs. 
Urinalysis showed blood 3+ and 24h proteinuria of 1.5 g. Renal ultrasound revealed normal sized kidneys 
with loss of parenchymal-sinus differentiation. Laboratory tests disclosed low C3, positive ANA but nega-
tive anti-dsDNA, SSA and SSB. Serum protein electrophoresis was normal. The renal biopsy showed 
tubulointerstitial nephritis with positive immunoglobulin staining involving the interstitium and tubular 
basement membrane with glomerular sparing. The patient started prednisolone (1mg/kg/day) without 
recovery of the renal function. Conclusion: Idiopathic hypocomplementaemic tubulointerstitial nephritis 
is a rare disease with few cases described in the literature. To our knowledge this is the first case 
reported in Portugal.
Key-Words: Hypocomplementaemia; idiopathic tubulointersticial nephritis; renal failure.
 RESUMO
A nefrite tubulo-intersticial (NTI) é uma causa comum de lesão renal, tipicamente associada a toma 
de fármacos, infecções ou doenças auto-imunes. No entanto, as NTI com deposição de imuno-complexos 
no interstício, sem envolvimento glomerular são raramente observadas. Apresentámos o caso de uma 
doente do sexo feminino, 64 anos, etnia indiana, admitida no nosso hospital, por insuficiência renal 
dependente de diálise. A análise sumária de urina revelou hematúria (3+) e a proteinúria nas 24h foi 
quantificada em 1,5g. A ecografia renal revelou rins de dimensões normais com perda da diferenciação 
parenquimo-sinusal. Analiticamente salienta-se, C3 baixo, ANA positivo, mas anticorpo anti dsDNA, SSA 
e SSB negativo. A electroforese de proteínas séricas não apresentava alterações. O doseamento de 
imunoglobulinas era normal, sem evidência de componente monoclonal. O restante estudo imunológico 
Idiopathic hypocomplementaemic 
tubulointerstitial nephritis
Nefrite túbulo-intersticial hipocomplementémica idiopática
Ana Azevedo1, Isabel Mesquita1, Helena Viana1, Gizela Rocha2, Carina Ferreira1, Vasco Fernandes1, António Murinello2, 
Fernanda Carvalho1, Fernando Nolasco2
1 Department of Nephrology, Hospital Curry Cabral, Centro Hospitalar de Lisboa Central. Lisboa, Portugal
2 Department of Medicine 1, Hospital Curry Cabral, Centro Hospitalar de Lisboa Central. Lisboa, Portugal
Received for publication: 08/09/2014
Accepted in revised form: 13/01/2015
CASE REPORT
Port J Nephrol Hypert 2015; 29(1): 71-77
Advance Access publication 2 March 2015
Nefro - 29-1 - MIOLO.indd   71 07/04/2015   11:51:58
72    Port J Nephrol Hypert 2015; 29(1): 71-77
Ana Azevedo, Isabel Mesquita, Helena Viana, Gizela Rocha, Carina Ferreira, 
Vasco Fernandes, António Murinello, Fernanda Carvalho, Fernando Nolasco
 INTRODUCTION
Tubulointerstitial nephritis is classified into aller-
gic, autoimmune, infectious and idiopathic1. Most 
forms of interstitial nephritis are cell mediated, with 
inflammatory infiltrates in interstitium without tubu-
lointerstitial immune deposits2. Interstitial nephritis 
with tubulointerstitial immune deposits and glomeru-
lar sparing can occur in Sjögren disease, lupus nephri-
tisand in other two recently described pathologies: 
IgG4-related systemic disease and idiopathic hypo-
complementaemic tubulointerstitial nephritis3.
Thirteen cases of idiopathic hypocomplementaemic 
tubulointerstitial nephritis have been described1,2,4-7. 
They were primarily characterized by tubulointerstitial 
immunological impairment and most patients were 
older men.
 CASE REPORT
A 64-year-old Indo-Caucasian woman, presented 
to our emergency room with lower limb oedema and 
dyspnoea for minimal exertion, with 2 weeks of evo-
lution and progressive worsening in the previous 
week. She also reported nocturia in the previous 3 
months and a progressive decrease in urine output 
in the last few days.
There was no history of arthralgia, alopecia, oral 
ulcers, Sicca syndrome, skin disorders, allergies, 
haematuria, foam urine, dysuria, fever, weight loss, 
nephrolithiasis, recurrent urinary tract infection, tak-
ing of NSAIDs, dietary supplements, natural medi-
cines, antibiotics. She also denied animal contact 
and recent trips. The patient was unaware of previous 
impaired renal function and she denied other 
pathologies.
The patient had been submitted to a radical hys-
terectomy, in 2008, due to a cervical carcinoma in 
situ and uterine myoma. She was kept under regular 
surveillance, without evidence of worsening. The 
patient related smoking and light alcohol consump-
tion habits in the past.
On admission, she was conscious, oriented, pale, 
afebrile and hydrated. She presented polypnoea, 
jugular engorgement (+++), inspiratory rales at both 
lung bases and peripheral oedema (+). Her blood 
pressure was 165/86mmHg. The remainder of her 
physical examination was unremarkable.
Initial laboratory testing results revealed abnormal 
levels of serum creatinine – 11.85mg/dl (GFR 4ml/
min/1.73m2, calculated by CKD-EPI creatinine equation), 
urea – 205mg/dl, potassium – 5.4mmol/l, calcium – 
6.2mg/dl, phosphorous – 10.3mg/dl, albumin – 2.5g/l. 
Serum levels of sodium, creatinine phosphokinase (CPK) 
and lactate dehydrogenase (LDH) were normal. The 
haemogram presented: haemoglobin – 8.0g/dl (normo-
cytic, normochromic), platelets – 254x10^3mm3, leuko-
cytes – 5x10^9/L; (neutrophil 73.4%, lymphocytes 21.5%, 
monocytes 1.8%, eosinophils 2.5%, basophil 0.8%). 
Arterial blood gases revealed a metabolic acidaemia: 
pH – 7.31 and HCO3- – 12mmol/l. Urinalysis showed 
haematuria and proteinuria (protein- 300mg/dL; blood- 
3+cells/HPF), many epithelial cells and no casts.
Renal ultrasound revealed normal sized kidneys 
with parenchymal-sinus differentiation loss.
The patient started haemodialysis through a tun-
nelized catheter and she was hospitalized for diag-
nostic and treatment guidance.
Subsequent laboratory study disclosed: low C3 
[55.2mg/dL (N = 75.0-140.0mg/dl)], normal C4, 
não apresentou alterações. Durante o internamento a doente realizou uma biópsia renal que mostrou 
nefrite tubulo-intersticial, com depósito de imunoglobulinas envolvendo o interstício e a membrana 
basal tubular, poupando os glomérulos. A doente iniciou terapêutica com prednisolona (1mg/Kg/dia), 
sem recuperação da função renal. A nefrite tubulo-intersticial hipocomplementémica idiopática é uma 
doença rara, com poucos casos descritos na literatura. Tanto quanto sabemos, este é o primeiro caso 
descrito em Portugal.
Palavras-Chave: Hipocomplementémia; insuficiência renal; nefrite túbulo-intersticial idiopática.
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positive ANA > 1:160 with fine granular pattern, angio-
tensin-converting-enzyme (ACE) 117U/L (N = 8-52 U/L) 
and iPTH of 841 pg/ml (N = 10-70). The remaining 
laboratory tests, including anti-dsDNA, anti-GBM, 
ANCA, rheumatoid factor, anti-Jo 1, anti-SSB/La, anti-
SSA/Ro, HBsAg, anti-HCV, anti-HIV and protein elec-
trophoresis, were negative. The serum immunoglobu-
lins IgA, IgM and IgG were normal  and there was no 
evidence of monoclonal component. The urinary 
immunofixation was unremarkable. Thyroid function 
tests were normal. The 24h proteinuria was 1.5g.
Complementary studies: chest X-rays, ECG and 
2D-echocardiogram did not reveal significant changes 
with the exception of a small pleural and pericardial 
effusion. The chest computed tomography excluded 
hilar lymphadenopathy. Bronchoscopy with bron-
choalveolar lavage did not show CD4/CD8 inversion. 
The performed ophthalmologic observation excluded 
granulomas, infection, uveitis and choroiditis.
Renal biopsy was performed and a total of 19 
glomeruli were obtained. Five glomeruli showed 
global sclerosis and six glomeruli showed segmental 
sclerosis lesions. The remaining glomeruli showed 
hypertrophy/hyperplasia of podocytes and Bowman’s 
capsule thickening (Figs. 1 and 2).
Large areas (> 90% of the sample) of interstitial 
fibrosis and tubular atrophy were observed with 
marked inflammatory infiltrate composed of mature 
lymphocytes, plasma cells and occasional neutrophils 
and eosinophils. No granuloma was observed (Fig. 3). 
There was fibrous thickening of arterial intima in 
medium size arteries without arteriolar hyalinosis.
Immunofluorescence in frozen section demon-
strated granular deposits in the interstitium and 
tubular basal membrane of IgG (++), C3 (++), C1q 
(++/+++), κ chain (+), IgG1 (++), IgG2 (++), IgG3 (+++) 
and IgG4 (++) (Fig. 4).
Characterization of infiltrate was made by immu-
nohistochemistry in paraffin section and revealed 
CD3 (+++), CD138 (++) and CD20 (+) (Fig. 5).
Figure 1
Diffuse mononuclear interstitial infiltrate (H&E; x200).
 
Figure 2
Interstitial infiltrate – eosinophilia (H&E; x400).
 
Figure 3
Interstitial infiltrate and fibrosis (Masson Trichrome; x200).
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We diagnosed this case as hypocomplementae-
mic idiopathic tubulointerstitial nephritis, and pred-
nisolone 1mg/kg/day (40 mg/day) was started. The 
patient was discharged 3 weeks after without renal 
function recovery. She remained on chronic hae-
modialysis programme and she had been followed-
up since discharge in the ambulatory clinic. She 
continued therapy with prednisone 40mg/day for 
4 months, without recovery of the renal function. 
However there was normalization of C3 levels 
(124mg/dL).
The patient was re-hospitalized, after this peri-
od, due to fever of unknown origin, associated 
with myalgia and tiredness. After aetiologic 
research, miliary tuberculosis was diagnosed. The 
patient began therapy with a 4-drug regimen (iso-
niazid, rifampin, pyrazinamide and ethambutol). 
During her stay in hospital, she suffered several 
healthcare associated infections, after which she 
suffered multi-organ failure, reason why the patient 
was transferred to an Intensive Care Unit. Here 
she needed invasive mechanical ventilation and 
vasoactive amines, and death occurred several 
days later.
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Figure 4








The interstitial infiltrate is composed of T cells (CD3 positive), B cells (CD20 
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 DISCUSSION
We present a case of a patient with renal failure, 
hypocomplementaemia (low C3), positive ANA, active 
urine sediment (blood 3+ cells/HPF) and 24h pro-
teinuria of 1.5g. She did not have eosinophilia and 
anti-dsDNA, SSA and SSB were negative. The biopsy 
revealed tubulointerstitial immunological damage 
with C3 and all IgG subtypes deposition in the tubular 
basement membrane (TBM) and interstitium, in a 
granular and diffuse pattern without glomerular 
involvement. We diagnosed this case as hypocomple-
mentaemic idiopathic tubulointerstitial nephritis, a 
very rare cause of tubulointerstitial nephritis1.
Tubulointerstitial nephritis is related to various 
causative factors, including infectious, allergic, toxic, 
autoimmune and idiopathic conditions2,8. Linear or 
granular TBM deposits may be found in systemic 
lupus erythematosus (SLE), Goodpasture’s syndrome, 
Sjogren’s syndrome (SS), and membranous glomeru-
lopathy, and rarely, usually with linear pattern, in 
drug-induced nephropathy secondary to methicillin 
and phenytoin1,2,4,5,9. It has also been described in 
urticarial vasculitis syndrome, adenovirus infection, 
renal allograft rejection or mixed cryoglobulinaemia4. 
The majority of these diseases have predominantly 
glomerular involvement, which was not present in 
our case. Predominant or isolated granular tubuloin-
terstitial deposits are usually restricted to autoim-
mune disorders, such as SLE, SS and IgG4-related 
systemic disease.
The SLE was excluded as the patient did not fulfill 
the American Rheumatology Association diagnostic 
criteria10.
Negative serology for anti-SSA/Ro and anti-SSB/
La and no symptoms or signs suggestive of SS ruled 
out this entity11.
The IgG4-related disease is a clinicopathological 
entity characterized by tumefactive lesions, a dense 
lymphoplasmocytic infiltrate rich in IgG4-positive 
plasma cells with fibrosis, and elevated total IgG or 
IgG4 in serum. In the kidney, the most dominant 
feature is a tubulointerstitial nephritis3. A Japanese 
group proposed a diagnostic algorithm for IgG4-
related kidney disease (IgG4 RKD)12. In accordance 
with this algorithm, IgG4 RKD should be suspected 
when some kidney damage is present associated to 
an elevated serum total IgG level, hypocomplemen-
taemia or an elevated IgE level. Other characteristics 
that help in the diagnosis of this entity are serum 
IgG4 level (> 135mg/dL), radiologic findings like dif-
fuse kidney enlargement, and a renal biopsy with 
evidence of plasma cell-rich TIN with > 10 IgG4+ 
plasma cells/HPF fill in the most concentrated field. 
Using this diagnostic algorithm for IgG4 RKD, we 
ruled out this hypothesis.
Only thirteen cases1,2,4-7 of idiopathic hypocomple-
mentaemic interstitial nephritis have been described 
in the literature. The largest series is that by Kamb-
ham et al. with eight cases reported2.
The significant varied nature between the reported 
cases challenged the possibility of a common aetiol-
ogy1,4, but kidney biopsies of the reported cases 
always showed TBM deposits with granular and pre-
dominantly diffuse staining for IgG. Hypocomplemen-
taemia, TBM immune complexes and glomerular 
sparing were consistent findings in all cases1,2,4,5. 
This indicates that the immune deposits in the TBM 
are capable of activating serum complement, leading 
to immune-mediated tubular injury1. C3 staining in 
the TBM was not, however, a consistent finding 
among the 13 cases, as also IgM, C1q, Lambda and 
kappa chains1,2,4-7. The pathogenesis of TBM depos-
its is unknown. The TBM antibody–antigen complex 
could result from either in situ immune complex 
formation or deposition of preformed circulating 
immune complexes1,5.
Tubulointerstitial nephritis with immune deposits 
seems to occur predominantly in older men with 
underlying immunologic disorders, including scleros-
ing cholangitis (two cases), marginal B cell lymphoma 
(one case), leucocytoclastic vasculitis (one case)2. 
Adult onset of diabetes mellitus and coronary artery 
disease were also present in five and six, respec-
tively1,2,6,7. However, in our case the patient was a 
woman and she did not present any known immu-
nologic condition.
Although experience in treating idiopathic hypo-
complementaemic tubulointerstitial nephritis is strict-
ly limited because of the few cases, the described 
ones were all treated with immunosuppressant drugs 
2,6,7 including, at least, prednisone. Renal function 
(reflected by serum creatinine) improved in 9/13 cases 
(significant in 6 patients)1,2,4,5. Prednisone doses 
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were not described in all reported cases but it seems 
that 1 mg/kg/day was consistent in more recent 
cases1,4,5.
It is unlikely that the remission noted in these 
patients was related to a particular immunosup-
pressant, because similar regimens were used in 
patients in whom there was no clinical improvement. 
The variability of treatment response indicates the 
potentially progressive nature of this disease1,5 and 
could be related with the presence of irreversible 
lesions/different degrees of chronicity4, although 
Vaseemuddin et al support that there is no appar-
ent correlation between biopsy findings and clinical 
progression1.
Even though, so far the few reports support an 
early5 and prolonged therapy1,4 with a median of 8.5 
months (3-20 months)4 that at least includes pred-
nisone. In the scenario of treatment failure, additional 
immunosuppressants could be associated1,4. In four 
cases, further immunosuppressant agents were add-
ed: in two cyclophosphamide, one tacrolimus plus 
mycophenolate mofetil and in the last case myco-
phenolic acid. The patients that have done cyclo-
phosphamide, one had a marginal B cell lymphoma, 
and another developed thrombotic thrombocytopenic 
purpura requiring plasmapheresis1. The third patient 
had cirrhosis and a monoclonal interstitial infiltrate 
and underwent liver transplantation several weeks 
after the biopsy, and was thereafter maintained on 
tacrolimus, mycophenolate mofetil and prednisone1. 
The last patient started mycophenolic acid after hyper-
glycaemic development allowing prednisone with-
drawl and subsequent glycaemic control4. Mycophe-
nolate mofetil has been reported as a useful 
therapeutic option for steroid-resistant acute inter-
stitial nephritis (AIN) and may be considered as 
potential first-line therapy in selected patients4.
There are no known indicators of disease progres-
sion or treatment response, but two prior cases1,4
have revealed normalization of the complement level 
as renal function enhanced. Hypocomplementaemia 
was suggested as a marker of clinical activity4.
In our case, given the patient history of cancer and 
the presence of large interstitial fibrosis and tubular 
atrophy, we choose to treat her only with corticoste-
roids, not associating any other immunosuppressor. 
We decided to extend therapy, because some similar 
cases with severe interstitial fibrosis and tubular atro-
phy have been published in which, after prolonged 
treatment with corticosteroids (3-9months), there was 
recovery of the renal function1,2.
Despite previous publications defined IgG4-related 
disease as being a systemic condition described in 
virtually every organ system1,4,5,9,10, Stone et al.
(2012) considered that many medical conditions that 
have long been viewed as disorders confined to 
single organs are part of the spectrum of IgG4-related 
disease. One of these suggested conditions is idio-
pathic hypocomplementaemic tubulointerstitial 
nephritis with extensive tubulointerstitial deposits13. 
Before Stone, Raissian et al. had already suggested 
that many patients diagnosed with idiopathic hypo-
complementaemic tubulointerstitial nephritis likely 
represent IgG4-related disease, especially those cases 
with associated immunologic conditions3. However, 
some diagnostic criteria to the IgG4 related disease12
have recently been published, which allow a higher 
homogeneity classifying this entity.
In summary, idiopathic hypocomplementaemic 
tubulointerstitial nephritis is differential diagnosis of 
renal failure and hypocomplementaemia, has a pro-
gressive nature and requires an early diagnosis and 
prolonged therapy.
Conflict of interest statement: None declared.
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